Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Emopamil-binding protein (EBP), also known as sterol Δ8-Δ7 isomerase, is an integral membrane protein located primarily in the endoplasmic reticulum of mammalian cells. EBP catalyzes a key step in cholesterol biosynthesis: the isomerization of the double bond from C8–C9 to C7–C8 in sterol intermediates, specifically converting 8,9-cholestenol into lathosterol. Mutations in *EBP* cause Conradi-Hünermann syndrome. Inhibition of EBP promotes oligodendrocyte formation and remyelination, and may also induce tumor cell death.
Inhibition of sterol Δ8-Δ7 isomerase activity, leading to disruption of cholesterol biosynthesis.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sterol Isomerase (Emopamil-Binding Protein) (None).